These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 35813759)

  • 1. A systematic review and meta-analysis of circulating cell-free DNA as a diagnostic biomarker for non-small cell lung cancer.
    He X; Chi Y; Peng J; Hu W; Ding C; Li B
    J Thorac Dis; 2022 Jun; 14(6):2103-2111. PubMed ID: 35813759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The value of serum Cyfra21-1 as a biomarker in the diagnosis of patients with non-small cell lung cancer: a meta-analysis.
    Cui C; Sun X; Zhang J; Han D; Gu J
    J Cancer Res Ther; 2014 Nov; 10 Suppl():C131-4. PubMed ID: 25450270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic value of cell-free DNA in thyroid cancer: A systematic review and meta-analysis.
    Hou F; Sun XD; Deng ZY
    Medicine (Baltimore); 2023 Feb; 102(7):e32928. PubMed ID: 36800605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic significance assessment of the circulating cell-free DNA in ovarian cancer: An updated meta-analysis.
    Li B; Pu K; Ge L; Wu X
    Gene; 2019 Sep; 714():143993. PubMed ID: 31330238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The diagnostic value of circulating cell free DNA quantification in non-small cell lung cancer: A systematic review with meta-analysis.
    Jiang T; Zhai C; Su C; Ren S; Zhou C
    Lung Cancer; 2016 Oct; 100():63-70. PubMed ID: 27597282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating HPV cDNA in the blood as a reliable biomarker for cervical cancer: A meta-analysis.
    Gu Y; Wan C; Qiu J; Cui Y; Jiang T; Zhuang Z
    PLoS One; 2020; 15(2):e0224001. PubMed ID: 32027658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic value of circulating cell-free DNA for renal cell carcinoma: a meta-analysis.
    Li Y; Chen P; Chen Z
    Transl Cancer Res; 2021 May; 10(5):2265-2276. PubMed ID: 35116544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating Cell Free DNA as the Diagnostic Marker for Ovarian Cancer: A Systematic Review and Meta-Analysis.
    Zhou Q; Li W; Leng B; Zheng W; He Z; Zuo M; Chen A
    PLoS One; 2016; 11(6):e0155495. PubMed ID: 27253331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating cell free DNA as the diagnostic marker for colorectal cancer: a systematic review and meta-analysis.
    Wang X; Shi XQ; Zeng PW; Mo FM; Chen ZH
    Oncotarget; 2018 May; 9(36):24514-24524. PubMed ID: 29849957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of Circulating Cell-free DNA to Diagnose Hepatocellular Carcinoma in Chinese Population: A Systematic Review and Meta-analysis.
    Aalami AH; Aalami F; Aliabadi EK; Amirabadi A; Sahebkar A
    Curr Med Chem; 2024; 31(22):3345-3359. PubMed ID: 37349993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A systematic review and meta-analysis of indirect comparison between miRNA and ctDNA in diagnosis of epithelial ovarian cancer.
    Fu X; Liu Y
    Transl Cancer Res; 2021 Dec; 10(12):5372-5382. PubMed ID: 35116384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic value of circulating free DNA for the detection of EGFR mutation status in NSCLC: a systematic review and meta-analysis.
    Luo J; Shen L; Zheng D
    Sci Rep; 2014 Sep; 4():6269. PubMed ID: 25201768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The diagnostic accuracy of circulating free DNA for the detection of KRAS mutation status in colorectal cancer: A meta-analysis.
    Xie W; Xie L; Song X
    Cancer Med; 2019 Mar; 8(3):1218-1231. PubMed ID: 30791218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Using artificial intelligence based imaging to predict lymph node metastasis in non-small cell lung cancer: a systematic review and meta-analysis.
    Chen L; Chen B; Zhao Z; Shen L
    Quant Imaging Med Surg; 2024 Oct; 14(10):7496-7512. PubMed ID: 39429617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic accuracy of circulating-free DNA for the determination of hepatocellular carcinoma: a systematic review and meta-analysis.
    Yinzhong W; Miaomiao W; Xiaoxue T; Qian W; Meng Q; Junqiang L
    Expert Rev Mol Diagn; 2023 Jan; 23(1):63-69. PubMed ID: 36633401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic value of microRNA-25 in patients with non-small cell lung cancer in Chinese population: A systematic review and meta-analysis.
    Li C; Sun L; Zhou H; Yang Y; Wang Y; She M; Chen J
    Medicine (Baltimore); 2020 Dec; 99(51):e23425. PubMed ID: 33371070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic Value of Concentration of Circulating Cell-Free DNA in Breast Cancer: A Meta-Analysis.
    Yu D; Tong Y; Guo X; Feng L; Jiang Z; Ying S; Jia J; Fang Y; Yu M; Xia H; Shi L; Lou J
    Front Oncol; 2019; 9():95. PubMed ID: 30881916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic Accuracy of PIK3CA Mutation Detection by Circulating Free DNA in Breast Cancer: A Meta-Analysis of Diagnostic Test Accuracy.
    Zhou Y; Wang C; Zhu H; Lin Y; Pan B; Zhang X; Huang X; Xu Q; Xu Y; Sun Q
    PLoS One; 2016; 11(6):e0158143. PubMed ID: 27336598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The potential diagnostic accuracy of circulating microRNAs for prostate cancer: A meta-analysis.
    Zhang WT; Zhang GX; Zhao RZ; Gao SS
    Actas Urol Esp (Engl Ed); 2022 Apr; 46(3):138-149. PubMed ID: 35260368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating donor-derived cell-free DNA as a marker for rejection after lung transplantation.
    Li Y; Liang B
    Front Immunol; 2023; 14():1263389. PubMed ID: 37885888
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.